Showing 1 - 5 of 5
While the COVID-19 pandemic has laid bare the large costs of infectious diseases, less attention has been paid to the impacts of more common, endemic respiratory viruses that frequently circulate in the population, especially when it comes to their potential long-term consequences for population...
Persistent link: https://www.econbiz.de/10012696433
Using micro data on virtually all of the drugs and diseases of over 500,000 people enrolled in Puerto Rico's Medicaid program, we examine the impact of the vintage (original FDA approval year) of drugs used to treat a patient on the patient's 3-year probability of survival, controlling for...
Persistent link: https://www.econbiz.de/10012467803
Two key issues for public insurance policy are the effect of insurance status on medical treatment, and the implications of insurance-induced treat- ment differentials for health outcomes. We address these issues in the context of the treatment of childbirth, using Vital Statistics data on every...
Persistent link: https://www.econbiz.de/10012472833
This paper uses data on health insurance choices by employees of Harvard University to examine the effect of alternative pricing rules on market equilibrium. In the mid-1990s, Harvard moved from a system of subsidizing more expensive insurance to a system of contributing an equal amount to each...
Persistent link: https://www.econbiz.de/10012473037
Michael Grossman's seminal publication on the demand for health and health production (Grossman 1972) has spawned a substantial body of research focusing on the production of infant health. This article provides a systematic review of the published literature to date on infant health production...
Persistent link: https://www.econbiz.de/10012453583